These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25445134)

  • 1. Antiplatelet therapy: risks and benefits of extended DAPT after stenting.
    Huynh K
    Nat Rev Cardiol; 2015 Jan; 12(1):1. PubMed ID: 25445134
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of dual antiplatelet therapy after drug-eluting stents.
    Sipahi I
    N Engl J Med; 2015 Apr; 372(14):1371. PubMed ID: 25830430
    [No Abstract]   [Full Text] [Related]  

  • 3. Duration of dual antiplatelet therapy after drug-eluting stents.
    Mauri L; Yeh RW; Kereiakes DJ
    N Engl J Med; 2015 Apr; 372(14):1373-4. PubMed ID: 25830429
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of dual antiplatelet therapy after drug-eluting stents.
    Tomoda H
    N Engl J Med; 2015 Apr; 372(14):1372-3. PubMed ID: 25830434
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of dual antiplatelet therapy after drug-eluting stents.
    Pfisterer M; Kaiser C; Jeger R
    N Engl J Med; 2015 Apr; 372(14):1372. PubMed ID: 25830433
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of dual antiplatelet therapy after drug-eluting stents.
    Marrs JC
    N Engl J Med; 2015 Apr; 372(14):1372. PubMed ID: 25830432
    [No Abstract]   [Full Text] [Related]  

  • 7. Duration of dual antiplatelet therapy after drug-eluting stents.
    Dohan JL
    N Engl J Med; 2015 Apr; 372(14):1371. PubMed ID: 25830431
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual antiplatelet therapy after drug-eluting stents--how long to treat?
    Colombo A; Chieffo A
    N Engl J Med; 2014 Dec; 371(23):2225-6. PubMed ID: 25399657
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding.
    Helft G
    Evid Based Med; 2015 Jun; 20(3):99. PubMed ID: 25743171
    [No Abstract]   [Full Text] [Related]  

  • 10. Balancing the risks and benefits of dual platelet inhibition.
    Keaney JF
    N Engl J Med; 2015 May; 372(19):1854-6. PubMed ID: 25773507
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events.
    Spencer FA; Guyatt G
    Ann Intern Med; 2015 Mar; 162(6):JC9. PubMed ID: 25775352
    [No Abstract]   [Full Text] [Related]  

  • 12. [The DAPT study].
    Pavasini R; Campo G; Limbruno U; De Servi S
    G Ital Cardiol (Rome); 2015; 16(7-8):393-8. PubMed ID: 26228607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Twelve or thirty months of dual antiplatelet Therapy after drug-eluting stents. Results of the DAPT trial].
    Liakishev AA
    Kardiologiia; 2015; 55(1):57-8. PubMed ID: 26050492
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial watch. DAPT study.
    Harv Heart Lett; 2010 Jan; 20(5):7. PubMed ID: 20217907
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
    Clemmensen P; Dridi NP; Holmvang L
    Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The ISAR-SAFE study].
    Capranzano P; Castiglioni B
    G Ital Cardiol (Rome); 2015 Jun; 16(6):331-5. PubMed ID: 26156693
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.
    Sarafoff N; Martischnig A; Wealer J; Mayer K; Mehilli J; Sibbing D; Kastrati A
    J Am Coll Cardiol; 2013 May; 61(20):2060-6. PubMed ID: 23524219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The illusion of "optimal" platelet inhibition.
    Steinhubl SR
    JACC Cardiovasc Interv; 2012 Mar; 5(3):278-80. PubMed ID: 22440492
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents.
    Migliorini A; Valenti R; Parodi G; Marcucci R; Abbate R; Carrabba N; Gensini GF; Antoniucci D
    Am J Cardiol; 2013 Dec; 112(12):1843-8. PubMed ID: 24063827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.